Certain Balance Sheet Items [Abstract] Certain Balance Sheet Items [Abstract] Construction-in-progress Construction in Progress, Gross Computer software Capitalized Computer Software, Gross Computer equipment Computer Equipment, Gross Amount before accumulated depreciation of computer equipment used in the normal conduct of business to produce goods and services and not intended for resale. Leasehold improvements Leasehold Improvements, Gross Machinery and equipment Machinery and Equipment, Gross Furniture and fixtures Furniture and Fixtures, Gross Land and buildings Land and Buildings, Gross Amount of real estate held for productive use and amount before accumulated depreciation of building structures held for productive use. Subtotal Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Inventory Disclosure [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Inventory, Net Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Accrued Liabilities [Member] Accrued Liabilities [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Selling, general and administrative [Member] Selling, General and Administrative Expenses [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] One-time Termination Benefits [Member] One-time Termination Benefits [Member] Facility Closing [Member] Facility Closing [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Balance, beginning of period Restructuring Reserve Costs incurred during the period Restructuring Charges Cash payments Payments for Restructuring Balance, end of period Property and Equipment Property, Plant and Equipment [Table Text Block] Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accounting Policies [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt [Member] Convertible Debt [Member] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Convertible Debt Securities [Member] Convertible Debt Securities [Member] Equity Options [Member] Equity Unit Purchase Agreements [Member] Warrants [Member] Warrant [Member] Ordinary shares under ESPP [Member] Equity Option [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Ordinary shares Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Interest rate Debt Instrument, Interest Rate, Stated Percentage Segment Reporting [Abstract] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Ireland [Member] IRELAND United States [Member] UNITED STATES Italy [Member] ITALY Other [Member] Other Countries [Member] Other Countries [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Property and equipment, net Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Research and development [Member] Research and Development Expense [Member] Cost of product sales [Member] Cost of Sales [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based compensation expense Allocated Share-based Compensation Expense Tax benefit from share-based compensation expense Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Total share-based compensation expense, net of tax Allocated Share-based Compensation Expense, Net of Tax Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Revenue, Goods, Net [Member] Sales Revenue, Goods, Net [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Express Scripts [Member] Express Scripts [Member] Express Scripts 1 [Member] McKesson [Member] McKesson Corporation [Member] McKesson Corporation [Member] Accredo Health Group, Inc. [Member] Accredo Health Group, Inc. [Member] Accredo Health Group, Inc. [Member] Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Percentage of total revenues Concentration Risk, Percentage Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Convertible Debt 2021 Notes [Member] Term Loans [Member] Term Loan [Member] Term Loan [Member] Other borrowings [Member] Other Borrowing [Member] Other Borrowing [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility [Member] Revolving Credit Facility [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Principal amount Long-term Debt, Gross Unamortized discount Debt Instrument, Unamortized Discount Total debt Long-term Debt Less current portion Long-term Debt, Current Maturities Total long-term debt Long-term Debt, Excluding Current Maturities Summary of Total Revenues Revenue from External Customers by Products and Services [Table Text Block] Summary of Total Revenues Attributed to Geographic Sources Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Summary of Revenues from Customers Representing More Than 10% of Total Revenues Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Total Long-Lived Assets by Location Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] Inventories Inventory Disclosure [Text Block] Long-term Debt, Fiscal Year Maturity [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] 2015 (remainder) Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2016 Long-term Debt, Maturities, Repayments of Principal in Year Two 2017 Long-term Debt, Maturities, Repayments of Principal in Year Three 2018 Long-term Debt, Maturities, Repayments of Principal in Year Four 2019 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total debt Commitments and Contingencies Disclosure [Abstract] Lease Payments Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2015 (remainder) Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2016 Operating Leases, Future Minimum Payments, Due in Two Years 2017 Operating Leases, Future Minimum Payments, Due in Three Years 2018 Operating Leases, Future Minimum Payments, Due in Four Years 2019 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due The Company and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table] Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Table] Schedule of Weighted Average Assumptions for Fair Values of Stock Options [Table] Plan Name Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Employee Stock Option [Member] Employee Stock Option [Member] Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items] Schedule Of Weighted Average Assumptions For Fair Values Of Stock Options [Line Items] Schedule of Weighted Average Assumptions for Fair Values of Stock Options[Line Items] Shares underlying options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Weighted-average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Weighted-average expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Range of risk-free rates, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Range of risk-free rates, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Stock Options [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Unrecognized compensation cost related to unvested stock option and RSUs Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period expected to be recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Stockholders' Equity Note [Abstract] Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Estimated Amortization Expense Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2015 (remainder) Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Total Finite-Lived Intangible Assets, Net Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Ordinary Options [Member] Ordinary Shares [Member] Ordinary Shares [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Stock Activity [Line Items] Class of Stock [Line Items] Total amount authorized for repurchase of shares under share repurchase program Stock Repurchase Program, Authorized Amount Shares repurchased Stock Repurchased and Retired During Period, Value Shares repurchased (in shares) Stock Repurchased and Retired During Period, Shares Average price of shares repurchased (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Future Minimum Lease Payments under Noncancelable Operating Leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] June 2015 Credit Agreement [Member] Credit Agreement June 2015 [Member] Credit Agreement June 2015 [Member] 2012 Credit Agreement [Member] Credit Agreement 2012 [Member] Credit Agreement 2012 [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) [Member] London Interbank Offered Rate (LIBOR) [Member] Prime Rate [Member] Prime Rate [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Principal amount Debt Instrument, Face Amount Credit facility maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Credit facility, amount outstanding Long-term Line of Credit Gross amount of debt extinguished Extinguishment of Debt, Amount Maturity date Debt Instrument, Maturity Date Variable interest rate Debt Instrument, Basis Spread on Variable Rate Commitment fee (percentage) Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Interest rate Debt Instrument, Interest Rate During Period Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Letters of credit, amount outstanding Letters of Credit Outstanding, Amount Interest rate Line of Credit Facility, Interest Rate at Period End Repayment of outstanding balance Repayments of Debt Principal repayment in year one and two (percent) Debt Instrument, Principal Repayment In Year One And Two, Percent Debt Instrument, Principal Repayment In Year One And Two, Percent Loss on extinguishment and modification of debt Gain (Loss) on Extinguishment and Modification of Debt Amount includes write-off of deferred debt financing costs, unamortized original issue debt discount and lender fees related to the early extinguishment and modification of debt. Principal repayment in year three (percent) Debt Instrument, Principal Repayment In Year Three, Percent Debt Instrument, Principal Repayment In Year Three, Percent Principal repayment in year four (percent) Debt Instrument, Principal Repayment In Year Four, Percent Debt Instrument, Principal Repayment In Year Four, Percent Principal repayment in year five (percent) Debt Instrument, Principal Repayment In Year Five, Percent Debt Instrument, Principal Repayment In Year Five, Percent Unamortized deferred financing costs and unamortized discount Write Off Of Unamortized Deferred Financing Costs And Unamortized Discount Write-off of amounts previously capitalized as original issue discount and deferred financing costs in an extinguishment of debt. Debt modification costs Debt Issuance Cost Carrying value of the equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Summary of stockholders equity Schedule of Stockholders Equity [Table Text Block] Components of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Statement of Comprehensive Income [Abstract] Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive income (loss) attributable to noncontrolling interests, net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income (loss) attributable to Jazz Pharmaceuticals plc Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Value Disclosures [Abstract] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value, Measurements, Recurring [Member] Eligible Item or Group for Fair Value Option Eligible Item or Group for Fair Value Option [Axis] Fair Value, Option, Eligible Item or Group [Domain] Fair Value, Option, Eligible Item or Group [Domain] Time deposits [Member] Bank Time Deposits [Member] Fair Value, Hierarchy Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Estimate of Fair Value Measurement [Member] Schedule of Available-for-sale Securities and Liabilities that are Measured at Fair Value [Line Items] Schedule of Available-for-sale Securities [Line Items] Estimated Fair Value Available-for-sale Securities Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Xyrem [Member] Xyrem [Member] Xyrem [Member] Erwinaze And Erwinase [Member] Erwinaze And Erwinase [Member] Erwinaze And Erwinase [Member] Sales Revenue, Product Line [Member] Sales Revenue, Product Line [Member] Product Concentration Risk [Member] Product Concentration Risk [Member] Idis Limited [Member] Idis Limited [Member] Idis Limited [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Product sales, net Sales Revenue, Goods, Net Percentage of product sales, net Number of ANDAs filed by third parties Loss Contingency, Pending Claims, Number Number of patents covering the distribution system Number Of Patents Related To Distribution System Number Of Patents Related To Distribution System Number of additional ANDA applicants Number Of Additional New Drug Application Applicants Number Of Additional New Drug Application Applicants Number of customers with significant accounts receivable Number Of Customers With Significant Accounts Receivable Balance Number of customers with significant amount of gross accounts receivable. Percentage of gross accounts receivable Entity Wide Accounts Receivable Major Customer Percentage Percentage of accounts receivable with significant customer Number of shares issuable from exchangeable senior notes Debt Instrument, Convertible, Number of Equity Instruments Debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Debt Long-term Debt [Text Block] Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Intangible asset amortization Amortization of Intangible Assets Share-based compensation Share-based Compensation Impairment charges Impairment of Intangible Assets, Finite-lived Depreciation Depreciation Acquired in-process research and development Research and Development Asset Acquired Other than Through Business Combination, Written-off Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Excess tax benefit from share-based compensation Excess Tax Benefit from Share-based Compensation, Operating Activities Acquisition accounting inventory fair value step-up adjustments Fair Value Inventory Step Up Adjustment The noncash expense recognized in the current period from the amortization of acquired inventory written up to fair value in purchase accounting. Deferred income taxes Deferred Income Tax Expense (Benefit) Provision for losses on accounts receivable and inventory Provision For Losses On Accounts Receivable And Inventory Amount of the current period expense charged against operations (1) for the purpose of reducing receivables to an amount that approximates their net realizable value and (2) the charge to cost of goods sold that represents the reduction off the carrying amount of inventory, generally attributable to obsolescence or market conditions. Amortization of debt discount and deferred financing costs Amortization of Financing Costs and Discounts Other non-cash transactions Other Noncash Income (Expense) Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Other long-term assets Increase (Decrease) in Other Noncurrent Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Income taxes payable Increase (Decrease) in Income Taxes Payable Deferred revenue Increase (Decrease) in Deferred Revenue Contingent consideration Increase Decrease in Contingent Consideration Increase Decrease in Contingent Consideration Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Net proceeds from sale of business Proceeds from Divestiture of Businesses Purchases of property and equipment Payments to Acquire Productive Assets Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Acquisition of in-process research and development Payments to Acquire In Process Research and Development Other Than Through Business Combination Payments to Acquire In Process Research and Development Other Than Through Business Combination Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Net proceeds from issuance of debt Proceeds from Issuance of Debt Proceeds from employee equity incentive and purchase plans and exercise of warrants Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises and from holders exercising their stock warrants. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately. Repayments of long-term debt Repayments of Secured Debt Payment of employee withholding taxes related to share-based awards Payments Related to Tax Withholding for Share-based Compensation Share repurchases Payments for Repurchase of Common Stock Excess tax benefit from share-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Acquisition of noncontrolling interests Payments to Acquire Additional Interest in Subsidiaries Payment of contingent consideration Payments for Previous Acquisition Repayments under revolving credit facility Repayments of Lines of Credit Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rates on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, at end of period Certain Balance Sheet Items Supplemental Balance Sheet Disclosures [Text Block] Commitments and Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Palo Alto [Member] Palo Alto [Member] Palo Alto [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Building [Member] Building [Member] Property and Equipment, Net [Member] Property, Plant and Equipment [Member] Other Non-Current Liabilities [Member] Other Noncurrent Liabilities [Member] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Pending Litigation [Member] Pending Litigation [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Xyrem ANDA Matters [Member] Xyrem ANDA Matters [Member] Xyrem ANDA Matters [Member] FazaClo ANDA Matters [Member] FazaClo ANDA Matters [Member] FazaClo ANDA Matters [Member] FazaClo [Member] FazaClo, Cutler Matter [Member] FazaClo, Cutler Matter [Member] Commitments and Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Line Items] Operating lease, term (in years) Lessee Leasing Arrangements, Operating Leases, Term of Contract Number of renewal option terms Lessee Leasing Arrangement, Operating Leases, Number Of Renewal Terms Number of renewal terms of the lessee's leasing arrangement. Operating lease, extended term option (in years) Operating Lease Extended Term Extended term option period for operating lease. Total future lease payments Other non-current liabilities Other Liabilities, Noncurrent Rent expense Operating Leases, Rent Expense Noncancelable purchase commitments, due within one year Unrecorded Unconditional Purchase Obligation, Due in Next Twelve Months Number of patents allegedly infringed upon Gain Contingency, Patents Allegedly Infringed upon, Number Court ordered stay period Loss Contingency, Court Ordered Stay, Term Court ordered stay period for the contingency. Number of patents named in CBM petitions Number Of Patents Named In Inter Partes Review (IPR) Petitions Total number of patents named in petitions for inter partes review (IPR). Number of ANDAs filed by 3rd parties Loss Contingency, New Claims Filed, Number Number of ANDAs outstanding Amounts sought in alleged breach of contractual obligations - minimum Loss Contingency, Range of Possible Loss, Minimum Amounts sought in alleged breach of contractual obligations - additional Loss Contingency, Estimate of Possible Additional Loss The estimated additional amount of possible loss from the contingency. Number of radiopharmaceutical products Loss Contingency, Radiopharmaceutical Products, Number Number of radiopharmaceutical products with possible loss contingency. Components of Inventories Schedule of Inventory, Current [Table Text Block] Income Statement [Abstract] Revenues: Revenues [Abstract] Royalties and contract revenues Royalties And Contract Revenues Royalties revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property and contract revenue earned during the period arising from products sold or services provided under the terms of a contract related to a particular project or product. Total revenues Revenues Operating expenses: Operating Expenses [Abstract] Cost of product sales (excluding amortization and impairment of intangible assets) Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment Total costs related to goods produced and sold during the reporting period excluding amortization of acquired developed technologies and intangible asset impairment presented separately. Selling, general and administrative Selling, General and Administrative Expense Research and development Research and Development Expense Total operating expenses Operating Expenses Income from operations Operating Income (Loss) Interest expense, net Interest Income (Expense), Nonoperating, Net Foreign currency gain (loss) Other Nonoperating Income Loss on extinguishment and modification of debt Income before income tax provision Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax provision Income Tax Expense (Benefit) Net income (loss) Net income (loss) attributable to noncontrolling interests, net of tax Net Income (Loss) Attributable to Noncontrolling Interest Net income (loss) attributable to Jazz Pharmaceuticals plc Net Income (Loss) Attributable to Parent Net income (loss) attributable to Jazz Pharmaceuticals plc per ordinary share: Earnings Per Share, Basic and Diluted [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Diluted (in dollars per share) Earnings Per Share, Diluted Weighted-average ordinary shares used in per share calculation - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted-average ordinary shares used in per share calculation - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Basic and Diluted Net Income per Ordinary Share Computation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Weighted-Average Ordinary Shares Excluded from Computation of Diluted Net Income per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Finite-Lived and Indefinite-Lived Intangible Assets [Table] Finite Lived And Indefinite Lived Intangible Assets [Table] Finite-Lived and Indefinite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Acquired developed technologies [Member] Developed Technology Rights [Member] Manufacturing Contracts [Member] Manufacturing Contracts [Member] Manufacturing Contracts [Member] Trademarks [Member] Trademarks [Member] Indefinite-lived Intangible Assets by Major Class Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Acquired IPR&D assets [Member] In Process Research and Development [Member] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Finite Lived And Indefinite Lived Intangible Assets [Line Items] Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] Remaining Weighted- Average Useful Life (In years) Finite-Lived Intangible Asset, Useful Life Gross Carrying Amount - Finite-Lived Intangible Assets Finite-Lived Intangible Assets, Gross Accumulated Amortization - Finite-Lived Intangible Assets Finite-Lived Intangible Assets, Accumulated Amortization In-process research and development Indefinite-lived Intangible Assets Acquired Gross Carrying Amount - Total Intangible Assets Intangible Assets, Gross (Excluding Goodwill) Net Book Value - Total Intangible Assets Intangible Assets, Net (Excluding Goodwill) Discontinued Operations and Disposal Groups [Abstract] Disposition Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net of allowances Accounts Receivable, Net, Current Inventories Prepaid expenses Prepaid Expense, Current Deferred tax assets, net Deferred Tax Assets, Net, Current Other current assets Other Assets, Current Assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Total current assets Assets, Current Intangible assets, net Goodwill Goodwill Deferred tax assets, net, non-current Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred financing costs Deferred Finance Costs, Current, Net Other non-current assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Current portion of long-term debt Income taxes payable Taxes Payable, Current Deferred tax liability, net Deferred Tax Liabilities, Net, Current Deferred revenue Deferred Revenue, Current Total current liabilities Liabilities, Current Deferred revenue, non-current Deferred Revenue, Noncurrent Long-term debt, less current portion Deferred tax liability, net, non-current Deferred Tax Liabilities, Net, Noncurrent Commitments and contingencies Commitments and Contingencies Jazz Pharmaceuticals plc shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Ordinary shares Common Stock, Value, Issued Non-voting euro deferred shares Nonvoting Euro Deferred Shares Shares issued to satisfy statutory minimum of Euro-denominated share capital required for a public limited company incorporated in Ireland. Capital redemption reserve Capital Redemption Reserve Capital redemption reserve created under Irish company law to preserve permanent capital in the company. Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total Jazz Pharmaceuticals plc shareholders’ equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders’ equity Liabilities and Equity Segment and Other Information Segment Reporting Disclosure [Text Block] Fair Value Measurement Fair Value Disclosures [Text Block] Equity [Abstract] Shareholders Equity [Table] Shareholders Equity [Table] Shareholders Equity [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Parent [Member] Parent [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Shareholders Equity [Line Items] Shareholders Equity [Line Items] [Line Items] for Shareholders Equity [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Shareholders equity, beginning of period Noncontrolling interests from the Gentium Acquisition Noncontrolling Interest, Increase from Business Combination Acquisition of noncontrolling interests Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Issuance of 1.875% exchangeable senior notes due 2021 Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Issuance of ordinary shares in conjunction with employee equity incentive and purchase plans and warrant exercises Stock Issued During Period, Employee Plans and Warrants, Exercises Value of stock issued as a result of the exercise of stock options and warrants and the employee stock purchase plan. Employee withholding taxes related to share-based awards Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation Share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Tax benefit from employee share options Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Shares repurchased Stock Repurchased During Period, Value Other comprehensive income (loss) Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Net income (loss) Shareholders equity, end of period Share-Based Compensation Expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Weighted-Average Assumptions Used in Black-Scholes Option Pricing Model which was Used to Estimate Grant Date Fair Value per Share Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Restricted Stock Unit activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Basis of Presentation Consolidation, Policy [Policy Text Block] Significant Risks and Uncertainties Significant Risks And Uncertainties [Policy Text Block] Describes risks and uncertainties related to the pharmaceutical industry. Concentrations of Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Net Income (Loss) Attributable to Jazz Pharmaceuticals plc per Ordinary Share Earnings Per Share, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restructuring Restructuring and Related Activities Disclosure [Text Block] Number of operating business segment Number of Operating Segments Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Axis] Disposal Groups, Including Discontinued Operations, Name [Domain] Disposal Group Name [Domain] Certain EUSA Products [Member] Portion Of EUSA [Member] Portion Of EUSA [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Consideration Disposal Group, Including Discontinued Operation, Consideration Loss on disposal Gain (Loss) on Disposition of Business Schedule of Long-term Debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-term Debt [Table Text Block] Fair Value Measurements [Table] Fair Value Measurements [Table] Fair Value Measurements [Table] Fair Value Measurements [Line Items] Fair Value Measurements [Line Items] Fair Value Measurements [Line Items] Fair value of exchangeable senior notes Convertible Debt, Fair Value Disclosures Rebates and other sales deductions Accrued Rebates And Other Sales Deductions Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and other sales deductions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Employee compensation and benefits Accrued Employee Benefits, Current Accrued milestone payment Accrued Milestone Payments Carrying value as of the balance sheet date of obligations incurred through that date and payable for milestones. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Sales returns reserve Sales Return Reserve Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales returns reserve. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Royalties Accrued Royalties, Current Professional fees Accrued Professional Fees, Current Accrued interest Accrued Interest Carrying value as of the balance sheet date of obligations incurred through that date and payable for interest. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued construction-in-progress Accrued Construction-In-Progress Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction-in-progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Other Other Accrued Liabilities, Current Total accrued liabilities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Income Taxes [Table] Income Tax Contingency [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Non-Taxable Jurisdiction [Member] Non-Taxable Jurisdiction [Member] Non-Taxable Jurisdiction [Member] Ireland [Member] Domestic Tax Authority [Member] Income Taxes [Line Items] Income Tax Contingency [Line Items] Effective income tax rate, percentage Effective Income Tax Rate Reconciliation, Percent Modified effective income tax rate, percentage Modified Effective Income Tax Rate, Continuing Operations Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations modified to exclude specific items. Effective statutory income tax rate, percentage Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Gross Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Gross Carrying Amounts and Net Book Values of Intangible Assets Schedule Of Finite Lived And Indefinite Lived Intangible Assets [Table Text Block] Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance, both finite life and indefinite life, by major class. Estimated Future Amortization Costs Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Foreign Currency Translation Adjustments [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward] Balance at December 31, 2014 Other comprehensive loss Balance at September 30, 2015 Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Cash, cash equivalents and marketable securities [Table] Cash Cash Equivalents And Marketable Securities [Table] Cash, cash equivalents and marketable securities [Table] Cash [Member] Cash [Member] Cash and cash equivalents [Line Items] Cash Cash Equivalents And Marketable Securities [Line Items] Cash, cash equivalents and marketable securities Amortized Cost Available-for-sale Securities, Amortized Cost Basis Gross Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Available-for-Sale Securities and Other Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Document And Entity Information [Abstract] Document And Entity Information Entities [Table] Entities [Table] Legal Entity Legal Entity [Axis] Entity [Domain] Entity [Domain] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Numerator: Numerator [Abstract] Numerator [Abstract] Net income (loss) attributable to Jazz Pharmaceuticals plc Denominator: Denominator [Abstract] Denominator [Abstract] Dilutive effect of employee equity incentive and purchase plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive effect of warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Weighted-average ordinary shares - diluted (in shares) Net income (loss) attributable to Jazz Pharmaceuticals plc per ordinary share: Earnings Per Share [Abstract] Basic net income (in dollars per share) Diluted net income (in dollars per share) Units granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Weighted average grand date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Defitelio [Member] Defitelio [Member] Defitelio [Member] Prialt [Member] Prialt [Member] Prialt [Member] Psychiatry [Member] Psychiatry [Member] Psychiatry [Member] Other [Member] Other Segments [Member] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning of period Foreign exchange Goodwill, Translation Adjustments Goodwill, end of period Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Europe [Member] Europe [Member] All Other [Member] Total revenues